An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia
Meliha Erman, Jianyun Zhang(Hohai University), David Seiden(Mount Sinai Medical Center), Gary Zammit(Merck & Co., Inc., Rahway, NJ, USA (United States)), Stephen M. Sainati
Cited by 435
Related Papers
Short Sleep Duration as a Risk Factor for Hypertension
|Hypertension|2006|1.2k
River dam impacts on biogeochemical cycling
|Nature Reviews Earth & Environment|2020|830
Global sensitivity analysis in hydrological modeling: Review of concepts, methods, theoretical framework, and applications
|Journal of Hydrology|2015|665
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*
|Critical Care Medicine|2010|500